Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 15, 2026 09:05 ET | Source: ProPhase Labs, Inc.

ProPhase Labs Reports Year-End 2025 Results, Highlights Accelerating Settlement Activity and Investment-Ready Crown Medical Collections Platform

$201.2 Million in Gross Claims with Expanding Settlement Activity Across Multiple Insurance Carriers Active Negotiations Support Estimated $50–$60 Million Net Recovery and Near-Term Cash Flow...
April 15, 2026 09:00 ET | Source: Cycurion

2026: A Breakout Year for Cycurion – Building Momentum and Shareholder Value

MCLEAN, Va., April 15, 2026 (GLOBE NEWSWIRE) -- Cycurion, Inc. (NASDAQ: CYCU) (“Cycurion” or the “Company”), a leading AI driven, tech-enabled cybersecurity solutions provider, today releases the...
April 15, 2026 08:30 ET | Source: GoldHaven Resources Corp.

GoldHaven Launches District-Scale Airborne Survey at Magno to Support 2026 Drilling

VANCOUVER, British Columbia, April 15, 2026 (GLOBE NEWSWIRE) -- GoldHaven Resources Corp. ("GoldHaven" or the "Company") (CSE: GOH) (OTCQB: GHVNF) (FSE: 4QS) is pleased to announce it has engaged...
April 15, 2026 08:15 ET | Source: Traws Pharma, Inc.

Traws Pharma Announces Up to $60 Million Private Placement Financing

Financing led by Sirenia Capital Management LP advances Traws Pharma's influenza program through a human challenge trial for tivoxavir marboxil in the United Kingdom NEWTOWN, Pa., April 15, 2026 ...
April 15, 2026 08:02 ET | Source: Sixty Degrees Pharmaceuticals

60 Degrees Pharma Announces ARAKODA (tafenoquine) for Malaria Prevention is Now Available on Runway Health Travel Website

ARAKODA® now available via Runway Health, enabling U.S. travelers to access once-weekly malaria prevention through a convenient telehealth platform.
April 15, 2026 08:00 ET | Source: Boehringer Ingelheim Limited

Boehringer Ingelheim and Zai Lab announce Collaboration on DLL3‑targeting T‑Cell Engager and ADC Combination in Small Cell Lung Cancer and Other Neuroendocrine Carcinomas

Boehringer Ingelheim and Zai Lab launch a clinical collaboration to evaluate a dual DLL3‑targeting combination therapy in small cell lung cancer (SCLC) and other neuroendocrine carcinomas (NECs). ...
April 15, 2026 08:00 ET | Source: Teva Pharmaceutical Industries Ltd

Teva Launches Home Ground™ Schizophrenia Community, a New Online Resource Hub for People Living with Schizophrenia and Their Care Partners

For people living with schizophrenia who may find daily disease management overwhelming due to fragmented support and resources, Home Ground™ Schizophrenia Community is a centralized destination that...
April 15, 2026 08:00 ET | Source: Achieve Life Sciences

Achieve Life Sciences Announces Operational Progress Including Completion of Technology Transfer to Adare Pharma Solutions

Adare Partnership Provides Supply Chain Redundancy and U.S.-based Manufacturing Capability Company Reiterates Guidance - If Approved, Cytisinicline Commercial Launch Expected in First Half of 2027 ...
April 15, 2026 08:00 ET | Source: Cue Biopharma, Inc.

Cue Biopharma to Present New Preclinical Data on Lead Autoimmune and Inflammatory Disease Candidate CUE-401 at IMMUNOLOGY2026

BOSTON, April 15, 2026 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and...
April 15, 2026 07:47 ET | Source: Mordor Intelligence

Microcrystalline Cellulose Market Led by the Wood-Based Segment with 57%+ Revenue Share; Market Projected to Reach USD 1.94 Billion by 2031, Reports Mordor Intelligence

Hyderabad, April 15, 2026 (GLOBE NEWSWIRE) -- According to a new report by Mordor Intelligence, the microcrystalline cellulose market is on a steady upward path, valued at USD 1.35 billion in 2025...